Expression of amphiregulin and epidermal growth factor receptor in human breast cancer: analysis of autocriny and stromal-epithelial interactions
about
Using a customized DNA microarray for expression profiling of the estrogen-responsive genes to evaluate estrogen activity among natural estrogens and industrial chemicals.Integration of molecular profiling and chemical imaging to elucidate fibroblast-microenvironment impact on cancer cell phenotype and endocrine resistance in breast cancerBRCA1 represses amphiregulin gene expression.EGFR signaling in breast cancer: bad to the bone.ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis.The ADAM17-amphiregulin-EGFR axis in mammary development and cancer.Oncogenic signaling in amphiregulin and EGFR-expressing PTEN-null human breast cancerMammary tumorigenesis induced by fibroblast growth factor receptor 1 requires activation of the epidermal growth factor receptor.Ridle for sparse regression with mandatory covariates with application to the genetic assessment of histologic grades of breast cancer.Epidermal growth factor receptor pathway analysis identifies amphiregulin as a key factor for cisplatin resistance of human breast cancer cells.Autocrine ligands of the epithelial growth factor receptor mediate inflammatory responses to diesel exhaust particlesLoss of HSulf-1 expression enhances autocrine signaling mediated by amphiregulin in breast cancer.Hypoxia induces epithelial amphiregulin gene expression in a CREB-dependent manner.Autocrine and juxtacrine effects of amphiregulin on the proliferative, invasive, and migratory properties of normal and neoplastic human mammary epithelial cells.Prognostic value of ERBB family mRNA expression in breast carcinomas.Differential Gene Expression in Ductal Carcinoma In Situ of the Breast Based on ERBB2 Status.
P2860
Q24812374-DAACFE59-44B3-45E9-B422-19273BADC671Q28538685-F021EE88-A60A-4E86-862C-0EA24DE7F766Q33630913-FAC122F0-8A51-462F-B23E-91ECCDDB5C96Q34348232-ECE0B35B-18BB-4E35-A8F3-E5FCE7765350Q34706896-88EE8AE6-D149-4BB3-BF4B-9C6241947082Q34777834-95DBFD98-18B8-4B65-9D11-12E128172A65Q35007438-35AFB296-611F-485E-BEBF-E7E886AF432BQ35784682-72DD926A-8A01-45AD-9975-B61145942B1AQ36260072-0330C2F6-7589-48BD-BFE0-DCACA38943D0Q37383705-C584F758-CD1F-44D2-8ED0-6D3F70108368Q37717386-717D47D2-E431-4E47-B461-B444DB580DFFQ38303667-DB6C25A0-E287-4DB6-B7B1-19CB8F56BA41Q38320250-E7923097-7252-4A78-B56A-999E136A6B99Q40221236-8E20FDB1-1715-4276-9B25-F0DEB2CC22DBQ43461671-A8C803A2-EF05-488C-A0E4-4C4CD86F8849Q51145791-091D8792-9DC7-4632-AB78-5DEB69F5C999
P2860
Expression of amphiregulin and epidermal growth factor receptor in human breast cancer: analysis of autocriny and stromal-epithelial interactions
description
article
@en
im August 2001 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2001
@uk
name
Expression of amphiregulin and ...... tromal-epithelial interactions
@en
Expression of amphiregulin and ...... tromal-epithelial interactions
@nl
type
label
Expression of amphiregulin and ...... tromal-epithelial interactions
@en
Expression of amphiregulin and ...... tromal-epithelial interactions
@nl
prefLabel
Expression of amphiregulin and ...... tromal-epithelial interactions
@en
Expression of amphiregulin and ...... tromal-epithelial interactions
@nl
P2093
P2860
P356
P1476
Expression of amphiregulin and ...... tromal-epithelial interactions
@en
P2093
Anne Janin
Anne de Roquancourt
Fabien Calvo
Guy Millot
Marc Espié
Michel Marty
Philippe Bertheau
P2860
P304
P356
10.1002/PATH.902
P577
2001-08-01T00:00:00Z